비알코올성 지방간 질환에 대한 침치료의 효과 : 체계적 고찰

키워드

참고문헌 (38)

2. Younossi ZM, "Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008", Clin Gastroenterol Hepatol, 9(6), pp.524~530.e1 (2011)
3. 김병익, "건강검진 수진자에서 비알코올성 지방간 및 간기능 장애: 인슐린 저항성과의 관계", 대한소화기학회지, 41(5), pp.366~373 (2003), 대한소화기학회
4. 정은행, "Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea", Clinical and Molecular Hepatology, 19(3), pp.266~272 (2013), 대한간학회[DOI]
6. The Spleen, "Expert consensus on TCM diagnosis and treatment of NAFLD", Beijing Journal of Traditional Chinese Medicine, 30(2), pp.83~86 (2011)
7. NIH Consensus Development Panel on Acupuncture, "NIH consensus conference. Acupuncture", JAMA, 280(17), pp.1518~1524 (1998)
8. Higgins JPT, "Cochrane handbook for systematic reviews of interventions", pp.187~242 (2008), Wiley-Blackwell
9. Huang Z, "Observation on clinical effects of acupoint thread-embedding method for non-alcoholic fatty liver disease", J Acupunct Tuina Sci, 14(03), pp.186~191 (2016)
11. Wang N, "Electroacupuncture at Jiaji(extra points)for 30 cases of nonalcoholic fatty liver disease", Zhongguo Zhen Jiu, 33(8), pp.717~718 (2013)
12. Lin JX, "Sixty cases of non-alcoholic fatty liver treated with TCM community comprehensive intervention", Henan traditional chinese medicine, 35(8), pp.1830~1832 (2015)
13. Xia SY, "Therapeutic observation of acupuncture plus Chinese herbal medicine for nonalcoholic fatty liver disease", Shanghai J Acu-mox, 34(5), pp.428~430 (2015)
14. Jin JJ, "Effects of acupoint -injection of Kaixilai on TG, TC, MDA, SOD, AST and ALT in the patient of non-alcoholic fatty liver", Zhongguo Zhen Jiu, 26(2), pp.100~102 (2006)
15. Meng SX, "Observation on therapeutic effect of acupuncture for treatment of patients with nonalcoholic steatohepatitis", Zhongguo Zhen Jiu, 29(8), pp.616~618 (2009)
16. Liu XD, "Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis", Zhongguo Zhen Jiu, 30(8), pp.637~641 (2010)
17. Zhou XL, "Effect of acupoint catgut embedding and Qiangganxiaozhi decoction on serum leptin and insulin resistance of nonalcoholic fatty liver disease", JETCM, 19(11), pp.1845~1847 (2010)
18. Zhou X, "Effects of catgut implantation and Qianggan Xiaozhi Yin on skin temperature of acupuncture point of foot three Yin meridians in patiens with nonalcoholic steatohepatitis", Modern journal of integrated Chinese traditional and western medicine, 20(31), pp.3909~3911 (2011)
19. Zhang QL, "Observation and nursing of non alcohol fatty liver disease treated with acupuncture therapy", Chinese community doctors, 31(32), pp.153~155 (2015)
20. Huang Z, "Non-alcoholic fatty liver disease of liver stagnation and spleen deficiency pattern treated with acupoint embedding therapy : a randomized controlled trial", Zhongguo Zhen Jiu, 36(2), pp.119~123 (2016)
21. 이창형, "알코올성 지방간 환자에 있어 전침 치료의 효과: 무작위 배정 대조군 연구", 한방비만학회지, 15(1), pp.1~8 (2015), 한방비만학회
22. "Wikipedia_Homeostatic model assessment"[URL]
23. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : Practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67(1), pp.328~357 (2018)
24. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), "Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report", Circulation, 106(25), pp.3143~3421 (2002)
25. Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112(17), 2735~2752
26. Hernaez R, "Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver : a meta-analysis", Hepatology, 54(3), pp.1082~1090 (2011)
27. Mottin CC, "The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients", Obes Surg, 14(5), pp.635~637 (2004)
28. Cho CS, "Preoperative radiographic assessment of hepatic steatosis with histologic correlation", J Am Coll Surg, 206(3), pp.480~488 (2008)
29. Bacon BR, "Nonalcoholic steatohepatitis : an expanded clinical entity", Gastroenterology, 107(4), pp.1103~1109 (1994)
30. Sorbi D, "The ratio of aspartate aminotransferase to alanine aminotransferase : potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease", Am J Gastroenterol, 94(4), pp.1018~1022 (1999)
31. Goldberg DM, "Structural, functional, and clinical aspects of gamma-glutamyltransferase", CRC Crit Rev Clin Lab Sci, 12(1), pp.1~58 (1980)
32. Lum G, "Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone", Clin chem, 18(4), pp.358~362 (1972)
33. Lim JS, "A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes : results from the Third National Health and Nutrition Examination Survey", Clin Chem, 53(6), pp.1092~1098 (2007)
34. Rio DD, "A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress", Nutr Metab Cardiovasc Dis, 15(4), pp.316~328 (2005)
35. Hayyan M, "Superoxide ion : generation and chemical implications", Chem Rev, 116(5), pp.3029~3085 (2016)
36. "Wikipedia_Superoxide dismutase"[URL]
37. Brennan AM, "Drug Insight : the role of leptin in human physiology and pathophysiology-emerging clinical applications", Nat Clin Pract Endocrinol Metab, 2(6), pp.318~327 (2006)
38. Pan H, "Advances in understanding the interrelations between leptin resistance and obesity", Physiol Behav, 130, pp.157~169 (2014)

관련 논문AI추천